Poly(2-oxazoline)s as new drug delivery systems Public Deposited

Downloadable Content

Download PDF
Last Modified
  • March 19, 2019
Creator
  • He, Zhijian
    • Affiliation: Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics
Abstract
  • Taxane drugs, a class of important cancer chemotherapeutics, are often associated with excipient-related hypersensitivity, severe neurotoxicity, peripheral neuropathy, drug resistance and other limitations that influence the patients' quality of life and treatment prognosis. In order to overcome these limitations, this dissertation research focuses on the new poly(2-oxazoline)s (POx) polymers as versatile nano-scale drug delivery systems. The synthesis and characterization of several new monomers including 2-benzyl-2-oxazoline, 2-methyl-2-oxazine, and a cationic monomer is summarized. In addition, the exploration of newly synthesized POx polymers using above monomers and new functionality groups (e.g. clickable initiator) are also briefly discussed. The potential of a specific doubly amphiphilic POx triblock copolymer (previously termed P2) is further explored as a polymeric micelle system in delivering taxanes (paclitaxel, the 3rd generation of toxoids, and multiple-drug combinations). The P2/paclitaxel micelle formulation is characterized by a facile preparation, up to 50 % wt. drug loading, excellent shelf stability, controllable sub-100 nm size, a very high maximum tolerated dose in mice, and a significant enhancement in efficacy when treating three different breast cancer models. In addition to paclitaxel, a number of 3rd generation toxoids able to avoid common drug resistance mechanisms, are formulated in P2 micelles. An excellent solubilization of different 3rd generation taxoids is achieved irrespective of drug structures with up to 46 % wt. drug loading and less than 100 nm micelle size. Furthermore, a selected formulation with the new taxoid SB-T-1214 shows about one to two orders of magnitude more active in vitro than paclitaxel in LCC6-MDR, a multidrug resistant breast cancer cell line. It significantly inhibits the growth of LCC6-MDR orthotropic tumors, outperforming Taxol and Cremophor formulated SB-T-1214. Moreover, a number of chemotherapeutic drugs are simultaneously formulated in P2 micelles. The multi-drug loaded P2 micelles indicate a ratio-dependent synergistic activity against multiple cancer cells in vitro. This dissertation also involves the study of a new and first cationic oxazoline monomer and corresponding polymer containing side-chain secondary amine groups. The cationic polymer is able to condense plasmid DNA into a sub 100 nm polyplex which is stable upon dilution in saline and thermal challenge. These polyplexes exhibit minimum serum protein binding and very low cytotoxicity in vitro compared to the polyplexes of DNA and commonly used poly(ethylene glycol)105-b-poly(L-lysine)51 (PEG-PLL). The in vitro transfection efficiency of the polypelxes is also studied in B16 murine melanoma cells as well as RAW264.7 macrophage cells. The cationic polymer represents a comparably safe and promising platform for delivering genes to macrophages and cancer cells. In summary, POx polymers are versatile and promising platforms for taxane anticancer drugs delivery and gene delivery.
Date of publication
Keyword
Subject
Identifier
Resource type
Rights statement
  • In Copyright
Advisor
  • Batrakova, Elena
  • Zamboni, William
  • Carey, Lisa
  • Kabanov, Alexander
  • Huang, Leaf
Degree
  • Doctor of Philosophy
Degree granting institution
  • University of North Carolina at Chapel Hill Graduate School
Graduation year
  • 2015
Language
Publisher
Place of publication
  • Chapel Hill, NC
Access
  • There are no restrictions to this item.
Parents:

This work has no parents.

Items